Health systems and hospitals
Digital Health Intelligence for Health Systems
Evaluate technology against a defined clinical or operational need before adding another disconnected tool to the health-system environment.
Translate a clinical or operational priority into a structured view of available technologies and models.
Compare evidence, interoperability, customer traction, workflow fit, maturity, and implementation risk.
Identify credible ventures and adjacent solutions without relying on inbound visibility or brand recognition.
The decision context
Hospital technology evaluation begins with the workflow, not the vendor list
Health systems must improve access, capacity, workforce productivity, quality, and patient outcomes while managing integration, security, procurement, and change. A promising product can still fail when the workflow, buyer, evidence, or implementation conditions are misunderstood.
Galen Growth structures the market around a specific clinical or operational problem, identifies relevant vendors, and compares evidence, adoption, maturity, and deployment experience so health-system teams can focus their diligence.
What Galen Growth evaluates
Healthcare innovation intelligence built for implementation
Each engagement starts with the decision, then brings together the market, company, clinical, partnership, and execution evidence required to answer it.
Clinical and operational landscape
Map technologies against a defined problem, care pathway, user group, and intended outcome.
Explore capability →02Digital health vendor evaluation
Build an evidence-led shortlist based on workflow fit, maturity, clinical proof, integration, and deployment history.
Explore capability →03Hospital technology due diligence
Pressure-test vendor claims, implementation dependencies, organisational resilience, and comparable adoption.
Explore capability →04Market and peer intelligence
Understand how peer health systems are investing, partnering, deploying, and scaling digital capabilities.
Explore capability →05Innovation portfolio review
Assess existing pilots and vendors for evidence, overlap, strategic contribution, and readiness to scale.
Explore capability →06System innovation strategy
Turn priority needs into a sequenced innovation agenda with clear evidence thresholds and decision gates.
Explore capability →Powered by HealthTech Alpha
A comparable view of products, evidence, and real market traction
HealthTech Alpha connects venture and product records with clinical evidence, regulatory position, partnerships, funding, customers, and market activity. This enables health systems to screen broadly, then investigate the vendors whose observable evidence matches the intended workflow.
Explore HealthTech Alpha- Clinical and operational use cases
- Customer and deployment signals
- Evidence and regulatory status
- Vendor maturity and resilience
Methodology
From strategic question to accountable action
- Define the need
Clarify the workflow, users, baseline, outcome, constraints, and evidence threshold.
- Map the vendor universe
Identify direct and adjacent solutions through a consistent taxonomy and search framework.
- Evaluate implementation fit
Compare evidence, interoperability, maturity, customer traction, and deployment dependencies.
- Prepare the decision
Deliver a transparent shortlist, diligence questions, risk view, and next-step plan.
Relevant work
How Galen Growth has supported related decisions
Selecting Cardiac Remote Monitoring Partners for Personalised Patient Care
Enabled BD and franchise teams to move decisively to partnership evaluation with a defensible top-10 list.
Read case study →Case studyBenchmarking Singapore’s Digital Health Ecosystem Against Global Peers
Enabled the agency to shape national programme design and strategic investment priorities with comparative evidence.
Read case study →Related intelligence
Research for this decision context
Explore Galen Growth analysis and reports built from the same digital health evidence base.
FAQ
Common questions
What does digital health strategy for health systems cover?
It connects priority clinical and operational needs with technology landscapes, vendor evaluation, implementation requirements, portfolio governance, and measurable outcomes.
How does Galen Growth evaluate digital health vendors?
We compare workflow fit, clinical evidence, regulation, interoperability, customer and partnership signals, organisational maturity, and implementation dependencies.
Can the work support a formal procurement process?
The intelligence can support requirements, market landscaping, longlisting, shortlisting, and diligence. Formal procurement and contracting remain with the health system.
Who we help